跳至主要内容
临床试验/KCT0008870
KCT0008870
招募中
未知

A multicentric prospective prognostic cohort with epidemiological, clinical, biological and treatment information to improve knowledge on lymphoma patients

Samsung Medical Center0 个研究点目标入组 2,000 人待定
适应症Neoplasms

概览

阶段
未知
干预措施
未指定
疾病 / 适应症
Neoplasms
发起方
Samsung Medical Center
入组人数
2000
状态
招募中
最后更新
2年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
待定
结束日期
待定
最后更新
2年前
研究类型
Observational Study
性别
All

研究者

入排标准

入选标准

  • 1\. Patients diagnosed with the following lymphoid malignancies through histopathological diagnostic procedures, regardless of whether they were previously treated:
  • 1\) Hodgkin lymphoma
  • 2\) B\-cell non\-Hodgkin lymphoma
  • 3\) T or NK cell non\-Hodgkin lymphoma
  • 4\) Diseases included in the category of lymphoid malignancies in other WHO classifications
  • 2\. Patients over 20 years of age
  • 3\. Patients who gave written consent to participate in a prospective cohort study

排除标准

  • 1\. In case of malignant tumor of the lymphatic system that falls under any of the following diseases:
  • yes; Plasma cell disease, amyloidosis
  • 2\. If you are a patient with the following lymphatic malignancies:
  • 1\) In case of follow\-up observation after diagnosis because treatment is not necessary
  • 2\) When only local radiation therapy is planned for the purpose of anticancer treatment
  • 3\) When using only antiviral drugs, antibiotics, or steroids rather than anticancer drugs for the purpose of anticancer treatment
  • 3\. Patients who do not understand or do not agree to written consent

结局指标

主要结局

未指定

相似试验